Proactive Investors - Run By Investors For Investors

Crop says cannabis business application for San Bernardino, California, reaches final stage

The Vancouver-based company said its executives will attend a special meeting of the mayor and city council to make a three-minute presentation followed by a question-and-answer session
Marijuana leaves in a cup of liquid
The cannabis dispensaries will operate under the brand Emerald Heights

Crop Infrastructure Corp (OTCMKTS:CRXPF) (CNSX:CROP) announced Tuesday that it has received confirmation that its San Bernardino, California, retail cannabis business application has reached the final phase.

The Vancouver-based company said in a statement that its executives will attend a special meeting of the mayor and city council to make a three-minute presentation followed by a question-and-answer session.

READ: Crop Infrastructure announces up to C$4M convertible debenture offering by the cannabis company

As announced on July 5, Crop agreed to finance the purchase of real estate upon the granting of a California dispensary license. Its proposed dispensaries will operate under the brand Emerald Heights.

“Crop has high expectations for Emerald Heights at this location,” CEO Michael Yorke said. “The team has done its market and location research very well and is now in the final phase of the application process in San Bernardino.”

Shares of the company traded at C$0.32 in Tuesday’s Canadian trading. They fetched US$0.25 on the OTC Markets.

Crop’s projects include operations in California, Washington State and Nevada.

Last week, the company announced its plan to raise as much as C$4 million in a senior secured convertible debenture offering.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CROP profile View Profile

Crop Infrastructure Corp. Timeline

Related Articles

cannabis bud on tray
Thu
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
data graphic
March 22 2019
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use